Short Information | Mesabi Trust (NYSE:MSB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,791 |
Total Actual Volume | 423,245 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 90 |
Average Short Percentage | 0.39% |
Is there a MSB Short Squeeze or Breakout about to happen?
See the MSB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-26-2024 | $17.23 | $17.63 | $17.65 | $17.1 | 22,129 | 20 | 0.09% |
06-14-2024 | $17.03 | $17.44 | $17.45 | $16.85 | 24,846 | 47 | 0.19% |
06-10-2024 | $17.42 | $17.21 | $17.42 | $17.05 | 17,439 | 100 | 0.57% |
06-06-2024 | $17.96 | $17.63 | $17.96 | $17.492 | 12,453 | 1 | 0.01% |
06-05-2024 | $17.97 | $18.1 | $18.25 | $17.8027 | 16,635 | 200 | 1.2% |
06-03-2024 | $17.85 | $18.52 | $18.52 | $17.58 | 32,365 | 125 | 0.39% |
05-31-2024 | $17.16 | $17.72 | $17.99 | $17.16 | 25,327 | 100 | 0.39% |
05-29-2024 | $16.86 | $16.96 | $17.0023 | $16.7 | 25,127 | 3 | 0.01% |
05-28-2024 | $17.4 | $16.92 | $17.4115 | $16.92 | 12,445 | 6 | 0.05% |
05-23-2024 | $17.63 | $17.29 | $17.67 | $17.0301 | 11,014 | 17 | 0.15% |
05-22-2024 | $17.7 | $17.64 | $17.9 | $17.47 | 15,383 | 5 | 0.03% |
05-16-2024 | $17.13 | $17.675 | $17.83 | $17.045 | 45,064 | 1 | 0% |
05-15-2024 | $16.88 | $17.24 | $17.25 | $16.88 | 18,228 | 38 | 0.21% |
05-14-2024 | $16.88 | $16.93 | $17.05 | $16.71 | 15,243 | 27 | 0.18% |
05-10-2024 | $16.66 | $16.68 | $16.72 | $16.5409 | 23,153 | 3 | 0.01% |
05-08-2024 | $16.68 | $16.73 | $16.82 | $16.6 | 13,136 | 1 | 0.01% |
05-03-2024 | $17.06 | $16.66 | $17.06 | $16.6 | 22,398 | 14 | 0.06% |
04-30-2024 | $16.7 | $16.08 | $16.9799 | $16.08 | 46,439 | 775 | 1.67% |
04-26-2024 | $17.35 | $17.31 | $17.45 | $17.14 | 11,707 | 194 | 1.66% |
04-24-2024 | $17.29 | $17.27 | $17.4235 | $16.96 | 12,714 | 114 | 0.9% |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file its Biologics License Application (BLA) for approval of Ryoncil ® (remestemcel-L) in the treat...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...
NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference. Dr. Itescu reiterated that the Company expects to file this quarter the Biologics License Applicati...